What are you most excited for about HIMSS20?
I’d say I’m most excited to get all of my steps in for the week with the 45,000 other attendees. But on a more serious note, healthcare is an enormously challenging industry that we have the privilege to work in. And what I look forward to most at HIMSS is the global convergence of healthcare stakeholders sharing their innovations and ideas around topics such as health, wellness, data exchange, interoperability, health analytics and outcomes, clinical decision support, and artificial intelligence.
It really represents a great learning and sharing opportunity. That opportunity gets me charged up about HIMSS20. I always come away with so many ideas around what healthcare’s most pressing issues are and what types of innovations people are bringing to light. I’m also enlightened about the potential synergies between organizations as I walk around the exhibit hall and better understand what unique solutions innovative companies are bringing to the market.
This year’s theme is “Be the Change”, focusing on reforming the health and wellness ecosystem with innovation driven by information and technology, so that all patients regardless of who they are or where they live, have access to everything they need to achieve overall wellbeing. Where do you see Cureatr’s place in this vision?
Over the last 18 months, Cureatr’s direction has become focused on addressing suboptimal medication management, healthcare’s epidemic problem. This issue is extremely costly, both in terms of dollars and lives, and frankly, has not received the amount of attention it merits given the magnitude of the problem. Relative to so many of the other very complicated issues in healthcare, there is a real opportunity to make a difference in improving medication safety with the application of the right tools and personnel. I find it encouraging that there is increasing awareness to the issue and the recent recognition in the industry that the patient needs to be brought into the fold.
In regards to “being the change” and providing patients with access to care regardless of who they are or where they live, Cureatr is doing a lot. Last year at HIMSS we showcased our medication management solution, Meds 360°, which provides current real time medication history, payment data if you will, and breaks down interoperability silos by allowing end users to see a patient’s medication history regardless of where the medication was prescribed. This year, we have expanded into offering technology-enabled services in which our own clinical telepharmacists proactively manage the medication therapies of high-risk patients in collaboration with the care team.
Finally, Cureatr is working on a patient self-service medication reconciliation platform, hopefully to be out this year. This will allow patients to verify each of their prescription and non-prescription medications prior to seeing their provider. The goal is to help provider organizations who may spend up to an hour trying to reconcile those medications on the patient's arrival into the office. It is our sincere belief is that medication reconciliation can be done much more efficiently and accurately through a self-service environment.
This year’s HIMSS includes 17 different education topics including consumerism and patient experience, data and analytics, population health, and telehealth to name a few. In which areas do you think Cureatr can make the most impact towards achieving HIMSS vision?
I think that Cureatr contributes to many of the educational tracks that HIMSS is offering this year. Our development work towards the patient self-service medication reconciliation platform mentioned above directly addresses patient engagement and experience and our CMM service is expanding what we thought possible with telehealth applications. But I’d like to address Cureatr’s strides towards population health and analytics in more detail.
We recently introduced the Meds 360° for Populations Dashboard. While working with risk bearing provider organizations and health plans, we are typically provided a roster of who they believe to be their highest risk patients derived from that organization’s analytics platform. These tools usually neglect which patients have high medication-related risk. What we have done with our population health dashboard is help organizations identify those patients with medication related risk. This time-consuming process is usually handled by the pharmacist, but now that time can be focused on patient care.
The population dashboard looks for specific medication related risk such patient’s such as polypharmacy, polyprescriber, or excessive fill gaps or suboptimal proportion of days covered on maintenance medications that point towards non-adherence. Likewise, that population dashboard looks for patients that have alerts generated for drug-to-drug interactions, therapeutic duplications, high-risk medications, particularly risky therapeutic categories, and potential controlled substance abuse. All of this allows providers to perform medication-related risk stratification that can guide and inform which patients need extra attention.
We understand that you are scheduled to speak at HIMSS on Wednesday, March 11, 4:15pm – 4:35pm in the HIMSS Value of Healthcare Pavilion. Can you give us a summary of what your talk will cover and why everyone should attend?
The talk will have three sections.
First, we are going to provide the audience with perspective on just how big a problem suboptimal medication management is. Recent research suggests that this could cost the US Healthcare system upwards of $528 billion annually. The main sources of the spend are hospitalization and long-term care admissions caused by preventable medication errors. Finally, the talk will highlight that this is largely caused by prescribing mishaps as opposed to patients not taking their medication as prescribed.
Second, we will provide an overview of Cureatr’s entire medication management suite. Starting with a demonstration of Meds 360° medication management as well as a preview of our patient's self-reconciliation. We'll provide the audience with a look into our new population dashboard we previously discussed. We will finish with a walk through of our comprehensive medication management service.
Last, we'll also take a look at anticipated return on investment of using Cureatr.
And of course, we will be thrilled to have a healthy dialogue with the audience and entertain any questions.
Make sure you visit Cureatr at HIMSS20 and come by for Dr. Ross’s talk. You can schedule a meeting with Cureatr beforehand by clicking here, or simply stop by kiosk 680-30 in the Value of Healthcare.